EMPERY ASSET MANAGEMENT, LP

Company

KIORA PHARMACEUTICALS INC

Filed

June 14, 2017

Accession Number

0000902664-17-002628

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →